Amyloid-recognizing drug has no effect in patients with a high-risk genetic background.
The way the disease tricks the body's defenses could help researchers develop better treatments.
Biologists have long wondered how our organs all grow at the same rate. Now theoretical physicists think they've found a clue in the special way sandpiles grow
A daily dose of Gilead's Truvada reduces infection in high-risk, uninfected men.
A study suggests that a gene-suppressant could someday be delivered via a cream.
The personal genetics company purchased disease-community website CureTogether earlier this week.
The success of "crowd-funding" inspired one researcher to create a Kickstarter-like service for scientists.
The virus is tamed in macaques.
Foundation Medicine will profile tumor genomes for Novartis' cancer drug trials.
Medicine has been revolutionised by 3D imaging techniques. But you ain't seen nothing yet, say data imaging researchers